Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 4/2012

01-04-2012 | Original Article – e-learning

Antithrombotic therapy in heart failure

Auteur: F. W. A. Verheugt

Gepubliceerd in: Netherlands Heart Journal | Uitgave 4/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Patients with congestive heart failure have a significant risk of stroke due to thromboembolism from the dilated left ventricle. Two relatively small trials suggest that oral anticoagulation with vitamin-K antagonists may reduce this risk when compared with placebo, aspirin or clopidogrel. However, more studies are eagerly awaited. So far, physicians seeing patients with heart failure should decide who needs antithrombotic prophylaxis on a case-by-case basis, especially since most heart failure patients have significant comorbidity precluding the use of oral anticoagulant.
Literatuur
1.
go back to reference Loh E, St John Sutton M, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–7.PubMedCrossRef Loh E, St John Sutton M, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–7.PubMedCrossRef
2.
go back to reference Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet. 2002;360:1037–43.PubMedCrossRef Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet. 2002;360:1037–43.PubMedCrossRef
3.
go back to reference Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004;10:101–12.PubMedCrossRef Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004;10:101–12.PubMedCrossRef
4.
go back to reference Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Heart Failure (WATCH) Trial. Circulation. 2009;119:1616–24.PubMedCrossRef Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Heart Failure (WATCH) Trial. Circulation. 2009;119:1616–24.PubMedCrossRef
5.
go back to reference Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies in patients with heart failure. Am Heart J. 2004;148:157–64.PubMedCrossRef Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies in patients with heart failure. Am Heart J. 2004;148:157–64.PubMedCrossRef
6.
go back to reference Masoudi FA, Wolfe P. Havranek, et al. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005;46:955–62.PubMedCrossRef Masoudi FA, Wolfe P. Havranek, et al. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005;46:955–62.PubMedCrossRef
Metagegevens
Titel
Antithrombotic therapy in heart failure
Auteur
F. W. A. Verheugt
Publicatiedatum
01-04-2012
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 4/2012
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0250-5

Andere artikelen Uitgave 4/2012

Netherlands Heart Journal 4/2012 Naar de uitgave